CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-26 | Greenstreet Yvonne Chief Executive Officer | Sale | −762 | $249.60 | $190K | 83,244 |
| 2024-11-26 | Greenstreet Yvonne Chief Executive Officer | Sale | −1,131 | $250.68 | $284K | 82,113 |
| 2024-11-26 | Greenstreet Yvonne Chief Executive Officer | Sale | −2,933 | $251.42 | $737K | 79,180 |
| 2024-11-26 | Greenstreet Yvonne Chief Executive Officer | Sale | −300 | $252.27 | $76K | 78,880 |
| 2024-11-26 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −30 | $247.77 | $7K | 19,109 |
| 2024-11-26 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −246 | $249.60 | $61K | 18,863 |
| 2024-11-26 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −364 | $250.68 | $91K | 18,499 |
| 2024-11-26 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −945 | $251.42 | $238K | 17,554 |
| 2024-11-26 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −97 | $252.27 | $24K | 17,457 |
| 2024-11-26 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −30 | $247.77 | $7K | 32,296 |
| 2024-11-26 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −246 | $249.60 | $61K | 32,050 |
| 2024-11-26 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −364 | $250.68 | $91K | 31,686 |
| 2024-11-26 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −945 | $251.42 | $238K | 30,741 |
| 2024-11-26 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −97 | $252.27 | $24K | 30,644 |
| 2024-11-26 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −26 | $247.77 | $6K | 14,634 |
| 2024-11-26 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −215 | $249.60 | $54K | 14,419 |
| 2024-11-26 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −318 | $250.68 | $80K | 14,101 |
| 2024-11-26 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −826 | $251.42 | $208K | 13,275 |
| 2024-11-26 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −84 | $252.27 | $21K | 13,191 |
| 2024-11-25 | Greenstreet Yvonne Chief Executive Officer | Grant or award | +10,658 | 84,099 |
Page 40 of 41 · 816 trades